How Data Gaps Impact COVID-19 Vaccine Hesitancy
This opinion piece was authored by Dr. Michelle Fiscus, a subject matter expert that consults for AIM. Note: this opinion piece is not an official AIM statement.
This opinion piece was authored by Dr. Michelle Fiscus, a subject matter expert that consults for AIM. Note: this opinion piece is not an official AIM statement.
This PowerPoint slide set was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to answer frequently asked questions about COVID-19 vaccine safety and dispel common myths about COVID-19 vaccines.
The 2023 AIM Leadership in Action conference took place from December 5-7, 2023, in Houston, TX, at the Westin Galleria Houston and featured leadership development and training, AIM awards, and…
This toolkit is designed to equip state Medicaid and immunization programs (IPs) with resources to help facilitate and support their goals.
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
AIM, in collaboration with the National Academy for State Health Policy and AcademyHealth, formed a new Vaccine Access Cooperative (VAC) to support collaboration between immunization programs, physicians, pharmacists, and more…
In episode six, Utah Department of Health and Human Services Immunization Director Rich Lakin shares his unique perspective on immunization work.
The 2022 Immunization Champions have been announced! Please read through to learn more about the 2022 Champions from various jurisdictions.
The Power of Providers (POP) Initiative is an innovative program that leverages healthcare providers by supporting their conversations about COVID-19 vaccines.
This toolkit contains materials programs can use throughout the launch, selection, and promotion of the 2024 Immunization Champion process.